Cancer Gene Therapy Market

Cancer Gene Therapy Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032
Frequently asked questions about this report

Cancer gene therapy is a treatment investigation method that includes inserting foreign genetic material (DNA or RNA) into the cells of a patient to combat or prevent disease.

North America accounted for a major share in the global cancer gene therapy market owing to well established healthcare infrastructure, and rising number of cancer patients across the region.

The global Cancer Gene Therapy market is estimated to exhibit a CAGR of 22% in terms of revenue over the forecast period.

Major participants in the cancer gene therapy industry comprise GlaxoSmithKline plc, Adaptimmune Therapeutics plc, Merck & Co., Inc., bluebird bio, Inc., Shanghai Sunway Biotech Co., Ltd, Celgene, SIBIONO, Anchiano Therapeutic, Achieve Life Sciences, Inc., and Synergene Active Ingredients Pvt. Ltd.